RRP15 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.733200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.699800E-01
Normal-vs-Stage2
7.714600E-01
Normal-vs-Stage3
6.622000E-01
Normal-vs-Stage4
1.852750E-01
Stage1-vs-Stage2
4.881000E-01
Stage1-vs-Stage3
2.408200E-01
Stage1-vs-Stage4
3.455200E-01
Stage2-vs-Stage3
3.783000E-01
Stage2-vs-Stage4
7.021600E-02
Stage3-vs-Stage4
9.575600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.839200E-01
Normal-vs-AfricanAmerican
9.928400E-02
Normal-vs-Asian
4.929800E-01
Caucasian-vs-AfricanAmerican
4.872500E-02
Caucasian-vs-Asian
3.411900E-02
AfricanAmerican-vs-Asian
1.221810E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.768200E-01
Normal-vs-Female
7.537000E-01
Male-vs-Female
9.316200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.164400E-01
Normal-vs-Age(41-60Yrs)
5.943800E-01
Normal-vs-Age(61-80Yrs)
8.851000E-01
Normal-vs-Age(81-100Yrs)
5.418000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.504200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.487200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.951400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.776400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.456400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.999600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.892000E-01
Normal-vs-Daily Drinker
8.670000E-01
Normal-vs-Weekly Drinker
7.943600E-01
Normal-vs-Occasional Drinker
3.543600E-01
Normal-vs-Social Drinker
7.655200E-01
Non Drinker-vs-Daily Drinker
5.107800E-01
Non Drinker-vs-Weekly Drinker
7.700400E-01
Non Drinker-vs-Occasional Drinker
1.038630E-01
Non Drinker-vs-Social Drinker
6.721800E-01
Daily Drinker-vs-Weekly Drinker
4.468600E-01
Daily Drinker-vs-Occasional Drinker
4.885800E-02
Daily Drinker-vs-Social Drinker
3.891600E-01
Weekly Drinker-vs-Occasional Drinker
3.019800E-01
Weekly Drinker-vs-Social Drinker
9.148000E-01
Occasional Drinker-vs-Social Drinker
3.820600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.569200E-01
Normal-vs-Grade 2
8.029700E-02
Normal-vs-Grade 3
1.068970E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.686600E-01
Grade 1-vs-Grade 3
2.777800E-01
Grade 1-vs-Grade 4
2.569200E-01
Grade 2-vs-Grade 3
5.912000E-01
Grade 2-vs-Grade 4
8.029700E-02
Grade 3-vs-Grade 4
1.068970E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.553000E-01
Normal-vs-NonDiabetic
7.803600E-01
Diabetic-vs-NonDiabetic
3.038400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.500400E-01
Normal-vs-NoPancreatitis
7.971600E-01
Pancreatitis-vs-NoPancreatitis
2.626200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.567000E-01
Normal-vs-N1
8.028800E-01
N0-vs-N1
4.771800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.445000E-01
Normal-vs-TP53-NonMutant
7.311000E-01
TP53-Mutant-vs-TP53-NonMutant
1.437010E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
